INDOCO REMEDIES Q2 FY27 (CONS.) ; NET PROFIT AT ₹19.47 CR VS LOSS OF ₹9.21 CR (YOY), DOWN 70.25% (QOQ)

REVENUE UP 7.32% AT ₹520.17 CR (YOY), UP 11.27% (QOQ) EBITDA UP 7.85% AT ₹46.43 CR (YOY), UP 13.19% (QOQ) MARGINS AT 8.93% VS 8.88% (YOY), 8.77% (QOQ)

INDOCO REMEDIES LTD.

← Back to feed